Abstract:Developmental toxicology is a constantly evolving research field which needs to attend to a complex underlying regulatory network. In order to ensure human health and environmental safety, new substances have to be tested for toxic effects on reproduction and development, before being commercialized. Traditional in vivo mammalian models represent the intricacy of human development and provide more adequately an assessment of the interaction of chemical compounds with the reproductive system. However, in the last years, the directives are to reduce the use of vertebrate animals, promoting their use only as a last resort. Consequently, the interest on the development and validation of alternative tests, able to cover the various aspects of the reproductive cycle, has significantly increased. Reproductive toxicity is probably the most difficult endpoint to be replaced by alternative assays, since it should provide information on mechanism interactions essential for female and male fertility and also knowledge on the animal development during the first phases of its life cycle. This complexity explains the slow progress in implementing alternative models for reproductive toxicity safety assays. Alternative test models may be based on in vitro systems and nonmammalian animal models. Many biological processes have been successfully addressed using in vitro models, opening the possibility to study the interference of teratogenic compounds. Their validation and implementation have lagged behind, in part because of difficulties in establishing their predictability. Nevertheless, the advance toward the process of validation is crucial to replace and reduce the use of living animals. Based on the present state of the art, it is not probable that such testing strategies will completely replace the need to assess reproductive toxicity in vivo in the near future, but they will contribute to reduce animal tests and will provide important information. In this chapter, the approved guidelines for standard methods and alternative methods, according to their regulatory and scientific status, are enumerated and briefly described.

Multi-cellular engineered living systems to assess reproductive toxicology

Synthetic human gonadal tissues for toxicology

Organs-On-Chip Models of the Female Reproductive System

Human organoid systems in modeling reproductive tissue development, function, and disease

The reprotoxic adverse side effects of neurogenic and neuroprotective drugs: current use of human organoid modeling as a potential alternative to preclinical models

Reproductive toxicology: keeping up with our changing world

Pluripotent stem cells for target organ developmental toxicity testing

Transforming Toxicity Assessment through Microphysiology, Bioprinting, and Computational Modeling

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Engineering a Computable Epiblast for in silico Modeling of Developmental Toxicity

Engineering microfluidic devices to mimic signaling cascades in continuous-flow cell culture as multiorgan microphysiological systems

Current strategies using 3D organoids to establish in vitro maternal-embryonic interaction

Organs-on-a-chip to understand reproduction

Placental microphysiological systems: new advances on promising platforms that mimic the microenvironment of the human placenta

Innovative explorations: unveiling the potential of organoids for investigating environmental pollutant exposure

Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities

A human population-based organotypic in vitro model for cardiotoxicity screening

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing

Guidelines on Developmental Toxicity Tests: Brief Insights

Animal-free assessment of developmental toxicity: Combining PBPK modeling with the ReproTracker assay

Organ-on-a-chip: future of female reproductive pathophysiological models